154 related articles for article (PubMed ID: 33506958)
21. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
[TBL] [Abstract][Full Text] [Related]
22. Determinants of the APTT- and ETP-based APC sensitivity tests.
de Visser MC; van Hylckama Vlieg A; Tans G; Rosing J; Dahm AE; Sandset PM; Rosendaal FR; Bertina RM
J Thromb Haemost; 2005 Jul; 3(7):1488-94. PubMed ID: 15978106
[TBL] [Abstract][Full Text] [Related]
23. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation.
Rassi AB; d'Amico EA; Tripodi A; da Rocha TRF; Migita BY; Ferreira CM; Carrilho FJ; Farias AQ
J Hepatol; 2020 Jan; 72(1):85-94. PubMed ID: 31536747
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation Effect and Safety Observation of Regional Citrate Anticoagulation for Double-Filtration Plasmapheresis in Critical Patients.
Peng X; Xie X; Yin J; Yu S; Zhang C; Zhao S
Blood Purif; 2020; 49(5):542-549. PubMed ID: 32191939
[TBL] [Abstract][Full Text] [Related]
25. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
26. Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes.
Lippi G; Salvagno GL; Tarperi C; Gelati M; Montagnana M; Danese E; Festa L; Sanchis-Gomar F; Favaloro EJ; Schena F
Semin Thromb Hemost; 2018 Nov; 44(8):747-755. PubMed ID: 30119138
[TBL] [Abstract][Full Text] [Related]
27. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
28. Conventional apheresis therapies: a review.
Ward DM
J Clin Apher; 2011; 26(5):230-8. PubMed ID: 21882233
[TBL] [Abstract][Full Text] [Related]
29. Feasibility, Efficacy, and Safety of Peripheral Venous Access for Chronic Double-Filtration Plasmapheresis with Regional Citrate Anticoagulation.
Cardinale A; Pambrun E; Prelipcean C; Messikh Z; Moranne O
Blood Purif; 2023; 52(7-8):621-630. PubMed ID: 37536292
[TBL] [Abstract][Full Text] [Related]
30. Double Filtration Plasmapheresis in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Dysfunction.
Cheng L; Tang YQ; Yi J; Ren Q; Yang XY; Gou SJ; Zhang L; Fu P
Blood Purif; 2020; 49(6):713-722. PubMed ID: 32294643
[TBL] [Abstract][Full Text] [Related]
31. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
32. Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels.
Hanafusa N; Satonaka H; Doi K; Noiri E; Fujita T
Ther Apher Dial; 2010 Jun; 14(3):287-91. PubMed ID: 20609180
[TBL] [Abstract][Full Text] [Related]
33. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
Youngwon N; Kim JE; Lim HS; Han KS; Kim HK
Biomed Res Int; 2013; 2013():856754. PubMed ID: 23555099
[TBL] [Abstract][Full Text] [Related]
34. Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuit.
Puppe B; Kingdon EJ
Clin Kidney J; 2014 Apr; 7(2):201-5. PubMed ID: 25852872
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis.
Dong J; Huang L; Li C; Wu B; Yang X; Ge Y
Lupus; 2023 Aug; 32(9):1066-1074. PubMed ID: 37487569
[TBL] [Abstract][Full Text] [Related]
36. How the direct oral anticoagulant apixaban affects thrombin generation parameters.
Tripodi A; Padovan L; Veena C; Scalambrino E; Testa S; Peyvandi F
Thromb Res; 2015 Jun; 135(6):1186-90. PubMed ID: 25895845
[TBL] [Abstract][Full Text] [Related]
37. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
38. Optimal Settings for Double Filtration Plasmapheresis With Targeted Removal Rate of Preexisting Antibody in Antibody-Incompatible Kidney Transplant.
Iwami D; Miura M; Chiba Y; Ota M; Matsumoto T; Hotta K; Sasaki H; Hirose T; Harada H; Shinohara N
Transplant Proc; 2018 Dec; 50(10):3478-3482. PubMed ID: 30577224
[TBL] [Abstract][Full Text] [Related]
39. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
40. Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction.
Coene J; Devreese K; Sabot B; Feys HB; Vandekerckhove P; Compernolle V
Transfusion; 2014 May; 54(5):1321-31. PubMed ID: 24472023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
